{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:02:33Z","timestamp":1783476153531,"version":"3.55.0"},"reference-count":5,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2023,11,16]],"date-time":"2023-11-16T00:00:00Z","timestamp":1700092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Dermatitis\u00ae"],"published-print":{"date-parts":[[2023,12,1]]},"DOI":"10.1089\/derm.2022.0065","type":"journal-article","created":{"date-parts":[[2023,2,27]],"date-time":"2023-02-27T07:41:53Z","timestamp":1677483713000},"page":"567-567","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":20,"title":["Failure of Dupilimab with Severe Prurigo Nodularis That Responded Well to Abrocitinib"],"prefix":"10.1177","volume":"34","author":[{"given":"Ashley","family":"Vander Does","sequence":"first","affiliation":[{"name":"Dr. Phillip Frost Department of Dermatology and Miami Itch Center, University of Miami, Miami, FL, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gil","family":"Yosipovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,11,16]]},"reference":[{"key":"e_1_3_1_2_2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2147\/ITT.S316602","article-title":"Immunotargets and therapy for prurigo nodularis","volume":"11","author":"Labib A","year":"2022","unstructured":"Labib A, , Ju T, , Vander Does A, et al. Immunotargets and therapy for prurigo nodularis. Immunotargets Ther, 2022; 11:11\u201321. doi:10.2147\/ITT.S316602.","journal-title":"Immunotargets Ther"},{"key":"e_1_3_1_3_2","doi-asserted-by":"crossref","unstructured":"Yosipovitch G Mollanazar NK Stander S et al. Dupilumab significantly improves itch and skin lesions in patients with prurigo nodularis: results from a 2nd phase 3 trial (LIBERTY-PN PRIME) [oral presentation]. EADV Congress. 2022 Milan Italy.","DOI":"10.26226\/m.63185c4d7e215f5e7f385086"},{"issue":"9","key":"e_1_3_1_4_2","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1111\/jocd.14709","article-title":"A prospective study examining the expression of STAT 1, 3, 6 in prurigo nodularis lesions with its immunopathogenic and therapeutic implications","volume":"21","author":"Agrawal D","year":"2022","unstructured":"Agrawal D, , Sardana K, , Mathachan SR, et al. A prospective study examining the expression of STAT 1, 3, 6 in prurigo nodularis lesions with its immunopathogenic and therapeutic implications. J Cosmet Dermatol, 2022; 21(9):4009\u20134015. doi:10.1111\/jocd.14709.","journal-title":"J Cosmet Dermatol"},{"issue":"2","key":"e_1_3_1_5_2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaad.2022.03.012","article-title":"Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: a case series","volume":"87","author":"Ju T","year":"2022","unstructured":"Ju T, , Labib A, , Vander Does A, et al. Topical Janus kinase-signal transducers and activators of transcription inhibitor tofacitinib is effective in reducing nonatopic dermatitis chronic itch: a case series. J Am Acad Dermatol, 2022; 87(2):400\u2013403. doi:10.1016\/j.jaad.2022.03.012.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"e_1_3_1_6_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/ced.14320","article-title":"Successful treatment of recalcitrant nodular prurigo with tofacitinib","volume":"45","author":"Molloy OE","year":"2020","unstructured":"Molloy OE, , Kearney N, , Byrne N, et al. Successful treatment of recalcitrant nodular prurigo with tofacitinib. Clin Exp Dermatol, 2020; 45(7):918\u2013920. doi:10.1111\/ced.14320.","journal-title":"Clin Exp Dermatol"}],"container-title":["Dermatitis\u00ae"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/derm.2022.0065","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2022.0065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/derm.2022.0065","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:07:03Z","timestamp":1777399623000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1089\/derm.2022.0065"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,16]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,12,1]]}},"alternative-id":["10.1089\/derm.2022.0065"],"URL":"https:\/\/doi.org\/10.1089\/derm.2022.0065","relation":{},"ISSN":["1710-3568","2162-5220"],"issn-type":[{"value":"1710-3568","type":"print"},{"value":"2162-5220","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,16]]}}}